Literature DB >> 15300175

Bile salt exposure causes phosphatidyl-inositol-3-kinase-mediated proliferation in a Barrett's adenocarcinoma cell line.

Kshama Jaiswal1, Vincent Tello, Christie Lopez-Guzman, Fiemu Nwariaku, Thomas Anthony, George A Sarosi.   

Abstract

BACKGROUND: The mechanisms by which gastroesophageal reflux promotes malignant progression in Barrett's esophagus are poorly understood. The phosphatidylinositol-3-kinase (PI3 kinase)/Akt pathway regulates proliferation and apoptosis. We hypothesized that the PI3 kinase/Akt pathway mediates the pro-proliferative and antiapoptotic effects of bile.
METHODS: The Barrett's adenocarcinoma cell line, SEG-1, was exposed to the conjugated bile salt, glycochenodeoxycholic acid (GCDA). Cell number was measured by the MTT incorporation assay and by Coulter counter. PI3 kinase/Akt activity was inferred from Western blots of phosphorylated and total Akt. Proliferation and apoptosis were determined by BrdU incorporation and cell death ELISA.
RESULTS: A dose-dependent cell number increase was seen with a 20-minute exposure to GCDA. On Western blot, 200 micromol/L GCDA caused a 3-fold increase in Akt phosphorylation within 20 minutes, which was inhibited by 90% with the addition of PI3 kinase inhibitor, LY294002. LY294002 produced dose-dependent inhibition of GCDA-induced cell number increases. 200 micromol/L GCDA decreased apoptosis by 25%. Addition of LY294002 did not completely inhibit the antiapoptotic effect of bile.
CONCLUSIONS: Bile salts activate the PI3 kinase/Akt signaling pathway and stimulate cell growth in SEG-1. The majority of this PI3 kinase-mediated effect is secondary to increases in proliferation rather than to decreases in apoptosis. Copyright 2004 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15300175     DOI: 10.1016/j.surg.2004.04.008

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  14 in total

1.  Radiofrequency ablation for dysplasia in Barrett's esophagus restores β-catenin activation within esophageal progenitor cells.

Authors:  K Krishnan; S Komanduri; J Cluley; R Dirisina; P Sinh; Jeff Z Ko; L Li; R B Katzman; T A Barrett
Journal:  Dig Dis Sci       Date:  2011-09-24       Impact factor: 3.199

2.  Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics.

Authors:  Jerzy Ostrowski; Michal Mikula; Jakub Karczmarski; Tymon Rubel; Lucjan S Wyrwicz; Piotr Bragoszewski; Pawel Gaj; Michal Dadlez; Eugeniusz Butruk; Jaroslaw Regula
Journal:  J Mol Med (Berl)       Date:  2007-03-30       Impact factor: 4.599

3.  Influence of acid and bile acid on ERK activity, PPARgamma expression and cell proliferation in normal human esophageal epithelial cells.

Authors:  Zhi-Ru Jiang; Jun Gong; Zhen-Ni Zhang; Zhe Qiao
Journal:  World J Gastroenterol       Date:  2006-04-21       Impact factor: 5.742

4.  Bile salts differentially sensitize esophageal squamous cells to CD95 (Fas/Apo-1 receptor) mediated apoptosis.

Authors:  Sanjay Naran; Peter Abrams; Pierre Queiroz de Oliveira; Steven J Hughes
Journal:  J Surg Res       Date:  2010-05-31       Impact factor: 2.192

Review 5.  Barrett's esophagus: a molecular perspective.

Authors:  Stuart Jon Spechler
Journal:  Curr Gastroenterol Rep       Date:  2005-06

6.  Induction of MUC5AC mucin by conjugated bile acids in the esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway.

Authors:  Shumei Song; James C Byrd; Sushovan Guha; Kai-Feng Liu; Dimpy Koul; Robert S Bresalier
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

7.  Amiloride and guggulsterone suppression of esophageal cancer cell growth in vitro and in nude mouse xenografts.

Authors:  Baoxiang Guan; Ashraful Hoque; Xiaochun Xu
Journal:  Front Biol (Beijing)       Date:  2014-02

8.  Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts.

Authors:  Baoxiang Guan; Hao Li; Zhengduo Yang; Ashraful Hoque; Xiaochun Xu
Journal:  Cancer       Date:  2012-12-20       Impact factor: 6.860

9.  Sorafenib triggers antiproliferative and pro-apoptotic signals in human esophageal adenocarcinoma cells.

Authors:  Jorge-Shmuel Delgado; Reba Mustafi; Jason Yee; Sonia Cerda; Anusara Chumsangsri; Urszula Dougherty; Lev Lichtenstein; Alessandro Fichera; Marc Bissonnette
Journal:  Dig Dis Sci       Date:  2008-05-30       Impact factor: 3.199

10.  Verification and unmasking of widely used human esophageal adenocarcinoma cell lines.

Authors:  Jurjen J Boonstra; Ronald van Marion; David G Beer; Lin Lin; Paula Chaves; Catarina Ribeiro; A Dias Pereira; Lúcia Roque; S Jane Darnton; Nasser K Altorki; David S Schrump; David S Klimstra; Laura H Tang; James R Eshleman; Hector Alvarez; Yutaka Shimada; Herman van Dekken; Hugo W Tilanus; Winand N M Dinjens
Journal:  J Natl Cancer Inst       Date:  2010-01-14       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.